Deal History
About us
The Company
Team
Offices
Globalscope
Worldwide
Canada
Denmark
France
Germany
Poland
Sweden
United Kingdom
USA
Services
Corporate Finance
Debt Advisory
Equity Research
Growth Equity Financing
IPO Strategy & Preparation
Industries
Business Services
Consumer & Internet
Industrial Technology
Life Science
Software & TMT
Energy & Infrastructure
Research
Equity Research
Macro and Markets
Career
Events
Insights
News
Company News
Deal News
In the Media
Newsletter
Contact
Newsletter
INT
DA
DE
FR
SV
US
Main menu button
Team
Deals
Contact
Team
Deals
Contact
News
All
Abera Bioscience
Adventure Box
Adverty
All for One Group
ALM Equity
Alzecure Pharma
Arctic Minerals
Biosergen
Candles Scandinavia
Carlsquare
CDON
CellaVision
CSAM Health Group
DanCann Pharma
Ecoclime
Elicera Therapeutics
Enrad
Frequentis
FRISQ
Future Gaming
GHP Specialty Care
GIAB
H&D Wireless
Hanza
Herantis Pharma
Immunovia
InCoax
Kancera
KlaraBo
Lohilo Foods
Lokotech
Medclair Invest
Midsummer
Mindark PE
Modus Therapeutics
Moninvent
NeoDynamics
Nischer Properties
Nosa Plugs
Observit
Orion Corporation
Pharmiva
Raytelligence
Risk Intelligence
SBB i Norden
Sensec
Spotlight Group
Svenska Aerogel
Teneo AI
Thinc Collective
Viva Wine Group
Ytrade Group
Zazz Energy
Zinzino
All
Company News
Deal News
Equity Research
Events
In the Media
Insights
Macro and Markets
23 Aug 2023
Equity Research, Pharmiva: Merger with Peptonic could spark the fire
Equity Research
Pharmiva
17 Aug 2022
First Impression Pharmiva, Q2, 2022: Growth picks up ahead of capital raise
Equity Research
Pharmiva
29 Jun 2022
Mrkt BUZZ Pharmiva: Vernivia on the move
Equity Research
Pharmiva
04 Apr 2022
Mrkt BUZZ Pharmiva: New CEO Appointed
Equity Research
Pharmiva
08 Mar 2022
Mrkt BUZZ Pharmiva: A Research and Professional Perspective on Vernivia
Equity Research
Pharmiva
24 Feb 2022
First Impression Pharmiva, Q4, 2021: Progress in Sweden
Equity Research
Pharmiva
03 Feb 2022
Mrkt BUZZ Pharmiva: Promising Start for Vernivia
Equity Research
Pharmiva
25 Jan 2022
Initiation of Coverage Pharmiva: Launch Should Provide Positive Momentum
Equity Research
Pharmiva